SCHEMBL9733448

SCHEMBL9733448

O=C(O)CCCCC(=O)c1cccc(F)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.58
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
HPGD P15428 1/20 0.41
P2RX1 P51575 1/20 0.41
P2RX7 Q99572 1/20 0.41
TBXAS1 P24557 1/20 0.40
PTPN1 P18031 1/20 0.40
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9733599 0.90 ALB (0.61) ALBHPGDP2RX1P2RX7PTPN1
SCHEMBL6383722 0.82 PTPN1 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7506003 0.80 HDAC3 (0.47) ALBHDAC3HDAC4HDAC1HDAC7
SCHEMBL1260174 0.79 ALB (0.56) ALBHDAC3HDAC1HDAC2HPGD
SCHEMBL7512933 0.79 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7503219 0.78 HDAC3 (0.45) ALBHDAC3HDAC4HDAC1HDAC7
SCHEMBL9077857 0.75 HDAC3 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4598039 0.75 ALB (0.60) ALBHDAC3HDAC1HDAC2P2RX1
SCHEMBL14732971 0.74 CTNNB1 (0.61) HPGDPTPN1ERCC5FEN1MAPT
SCHEMBL1516668 0.74 ALB (1.00) ALBHPGDP2RX1P2RX7CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed